These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37181806)

  • 1. INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Li W; Hong G; Lai X
    Mediators Inflamm; 2023; 2023():7057236. PubMed ID: 37181806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Lu Y; Chen S; Wang Q; Zhang J; Pei X
    J Oncol; 2022; 2022():1939368. PubMed ID: 36059812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Chen T; Zhu C; Wang X; Pan Y
    Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
    Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
    Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation.
    Su Y; Xie R; Xu Q
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Long Noncoding RNAs,
    Qin Y; Tu X; Huang M; Ma C; Huang Q; Huang Q; Shu H; Ou C
    DNA Cell Biol; 2023 Aug; 42(8):488-497. PubMed ID: 37527208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.
    Ma Y; Sun WL; Ma SS; Zhao G; Liu Z; Lu Z; Zhang D
    BMC Bioinformatics; 2023 Feb; 24(1):54. PubMed ID: 36803542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma.
    Zhang H; Yuan J; Xiang Y; Liu Y
    J Oncol; 2022; 2022():2099327. PubMed ID: 36284635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells.
    Liu W; Huai R; Zhang Y; Rao S; Xiong L; Ding R; Mao C; Zhao W; Hao T; Huang Q; Guo Z
    Genes Genomics; 2019 Aug; 41(8):951-959. PubMed ID: 31066006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
    Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
    Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
    Front Immunol; 2022; 13():892750. PubMed ID: 35812416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.